Context:

A study of 84,472 social media posts across Facebook, TikTok, Instagram, and YouTube found that high-engagement discussions about prescription drugs often lack transparency and risk information, with a notable influence from undisclosed promotional content. Among 740 posts flagged for FDA/FTC oversight relevance, about 80% contained potentially undisclosed influencer promotion and only 2.2% carried explicit sponsorship tags, while many posts omitted adverse effect information. Patients or consumers dominated the sources (about two-thirds), with influencers also contributing, and pharmaceutical companies comprising a small share, raising concerns about balanced messaging. The majority claimed drug efficacy, yet only a minority addressed risks, signaling a skewed information environment. The findings, published online in JAMA (Nov 13, 2025) and led by Alex Kresovich, call for greater transparency and regulatory attention to ensure accurate, balanced guidance for patients.

Dive Deeper:

• The analysis examined 84,472 posts across Facebook, TikTok, Instagram, and YouTube, narrowing to 740 high-engagement posts relevant to FDA or FTC oversight on prescription drugs such as GLP-1 agonists, ADHD stimulants, and autoimmune biologics.

• Promotional content from influencers was potentially undisclosed in 80.1% of these high-engagement posts, while explicit sponsorship tags appeared in only 2.2% of cases.

• Sources were dominated by patients or consumers (65.9%) and influencers (42.7%), with pharmaceutical companies contributing just 4.5%; promotional language appeared in 23.6% of posts, most prominently on Instagram (33.0%).

• Calls to action, such as urging readers to ask a doctor or visit a site, appeared in 15.7% of posts, with the highest prevalence on Instagram (23.1%).

• About 69.1% of posts made efficacy claims, but only 32.3% mentioned risks or adverse effects, suggesting a skewed information environment regarding drug safety and effectiveness.

• The study, funded by Arnold Ventures and led by PhD Alex Kresovich of the University of Chicago, underscores the need for transparency and regulatory oversight to improve the quality of health information encountered on social media.